US Patent Issued to FBD Biologics on March 24 for "CD47/pd-L1-targeting protein complex and methods of use thereof" (Taiwanese Inventors)

ALEXANDRIA, Va., March 24 -- United States Patent no. 12,583,926, issued on March 24, was assigned to FBD Biologics Ltd. (Tsim Sha Tsui, Hong Kong).

"CD47/pd-L1-targeting protein complex and methods of use thereof" was invented by Jiin-Tarng Wang (Taichung City, Taiwan), Han-Fang Teng (New Taipei City, Taiwan), Yun-Chih Cheng (Taipei, Taiwan), Pan-Hsien Kuo (Taoyuan City, Taiwan), Chieh-Hsin Ho (Taipei, Taiwan), Wei-Tse Sun (Taipei, Taiwan), Chia-Zhen Wu (Taipei, Taiwan), Tsai-Kuei Shen (Taipei, Taiwan), Chi-Ling Tseng (Taipei City, Taiwan) and Zong Sean Juo (New Taipei City, Taiwan).

According to the abstract* released by the U.S. Patent & Trademark Office: "This disclosure relates to protein complexes targeting CD47, PD-L1, and/or TGFBe...